TAVR at 3 years showed durable benefits vs surgery: the Evolut Low Risk Trial
Key Points Both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) procedures offer options for intervention in patients... Read more.
TRILUMINATE: Tri-Clip reduces tricuspid regurgitation and improves quality of life at one year
Key Points: There have been limited data examining the safety and efficacy of transcatheter tricuspid repair systems. In the TRILUMINATE study, Tri-Clip was compared... Read more.
FLAME: FlowTriever use for PE associated with decreased in-hospital adverse outcomes
Key Points: Mortality in high-risk PE remains unacceptably high (25%) despite advances in medical and interventional therapies. The FLAME study was a prospective,... Read more.
Intravascular Imaging-Guiding PCI in Complex Coronary Lesions Linked to Better Outcomes: The RENOVATE-COMPLEX-PCI Study
Key Points: Intravascular imaging-guided PCI shows promise in improving outcomes for patients with complex coronary artery lesions, with a 36% reduction on the primary... Read more.
TARGET Trial: On-site CT-FFR Feasible and Effective in stable CAD
Key points: The TARGET trial is the first randomized trial designed to assess the impact of an on-site CT-FFR strategy using machine learning compared to standard... Read more.
HALO – Baxdrostat Fails to Beat Placebo for Blood Pressure Reduction in Uncontrolled Hypertension
Key Points Baxdrostat, a highly selective aldosterone synthase inhibitor, reduced systolic blood pressure as compared with placebo among patients with resistant... Read more.
Evolocumab Effect on Plaque Characteristics in Stable CAD Patients
Key Points The YELLOW III study aimed to assess the effect of 26 weeks of evolocumab on plaque morphology using intravascular imaging (OCT and NIRS/IVUS) and peripheral... Read more.
No difference in Heart Failure Outcomes with Advanced Imaging modalities vs SPECT: The AIMI-HF Trial
Key Points: Imaging may be underused in patients with ischemic heart failure (HF) to evaluate ischemia/viability and guide management. The Alternative Imaging Modalities... Read more.
Viability Not Linked to Survival or LV improvement: The REVIVED-BCIS2 Randomized Trial
Key Points: -It is unclear whether myocardial viability tests should be used to guide decisions about revascularization in patients with ischemic cardiomyopathy... Read more.
Atorvastatin Reduced Left Ventricular Dysfunction From Anthracyclines: The STOP-CA Trial
Key Points -Anthracycline therapy is associated with the development of heart failure, yet anthracyclines are among the most widely used and most effective... Read more.
